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Abstract Radiotherapy of the laryngopharynx sometimes
leads to functional disabilities including swallowing dys-
function. One of the reasons for these disabilities is a dete-
rioration of laryngeal sensation. Laryngeal sensation is an
important factor in swallowing, but quantitative evaluation
of laryngeal sensation has been diYcult. In this study, we
evaluated changes in laryngeal sensation before and after
radiotherapy for laryngeal and hypopharyngeal cancer,
using a Xexible laryngoscope and probes. This study was
conducted in 12 patients, 8 with laryngeal cancer and 4
with hypopharyngeal cancer, who received radiotherapy
alone or chemoradiotherapy at our medical centre. Mea-
surements were performed using a 3.3-mm-diameter Xexi-
ble laryngoscope with a probe port and four types of probes
with 0.06-, 0.13-, 0.20-, and 0.30-mm nylon Wlaments
attached to a wire tip. Sensation was evaluated at the tip of
the epiglottis and the arytenoid region. Measurements were
performed before radiotherapy, 1, 3 months, and 1 year
after completion of radiotherapy. Sensation of the epiglottis
and arytenoid deteriorated signiWcantly 1 and 3 months
after radiotherapy compared with before radiotherapy.
Laryngeal sensation recovered in most cases within 1 year
after radiotherapy. The present study clearly demonstrates
the deterioration of laryngeal sensation with radiotherapy.
Keywords Laryngeal sensation · Laryngeal sensory 
testing · Radiotherapy · Flexible laryngoscope and probes
Introduction
Radiotherapy for laryngopharyngeal cancer plays an impor-
tant role for organ preservation [1–3]. However, it some-
times leads to functional disabilities including swallowing
dysfunction [2–5]. One of the reasons for these disabilities
is a deterioration of laryngeal sensation. Laryngeal sensa-
tion is an important factor in swallowing [6–9], but quanti-
tative evaluation of laryngeal sensation has been diYcult.
Aviv et al. described the use of an air-puV stimulator for
quantitative evaluation of laryngeal sensation [7, 10], but
such testing has been limited because of the special equip-
ment required. In the present study, a novel method to mea-
sure laryngeal sensation using a Xexible laryngoscope and
probes previously developed by Yaguchi et al. was used
[11, 12]. Yaguchi et al. evaluated and compared laryngeal
sensation in young adults and elderly individuals using this
method. In the present study, the same method was used to
evaluate changes in laryngeal sensation before and after
radiotherapy for laryngeal and hypopharyngeal cancer.
Materials and methods
This study was approved by the ethics committee and insti-
tutional review board of our hospital (No. 534, 534-2). All
patients provided their written informed consent.
The study involved 12 patients with laryngeal (n =8 )  o r
hypopharyngeal cancer (n = 4) who did not undergo sur-
gery for the primary lesion, and underwent either radiother-
apy alone or chemoradiotherapy. The patients’ mean age
was 66.2 years (range 53–78 years). Four patients under-
went radiotherapy alone, and eight underwent chemoradio-
therapy. All patients achieved a complete response of the
primary lesion. In two patients, neck dissection on the side
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of the lesion was performed within 1 month after complet-
ing radiotherapy for residual cervical lymph nodes. Table 1
shows the patients’ characteristics.
The test procedure was as follows. A novel Xexible
laryngoscope (ENF-Y0005), with a maximum diameter of
3.3 mm and a 1.2-mm probe port was co-developed with
Olympus (Tokyo, Japan) in previous research [11,  12].
When compared with a conventional Xexible laryngoscope
with a forceps port, this Xexible laryngoscope is narrower,
has a curvature angle of 130°, and has excellent manoeu-
vrability (Fig. 1). The probes, also co-developed with
Olympus, have a nylon Wlament attached to a wire tip and
are protected by a sheath to prevent entanglement with the
Xexible laryngoscope. Four types of probes with nylon Wla-
ment diameters of 0.06, 0.13, 0.20, and 0.30 mm were used
(Fig. 1). These were prepared based on Semmes–Weinstein
monoWlaments, which are used to test sensation, for exam-
ple, in diabetic peripheral neuropathy [12]. At the time of
the study, the Xexible laryngoscope and probes had not yet
become commercially available, and they were provided by
Olympus.
To insert the Xexible laryngoscope without using intra-
nasal anaesthesia, 1:2,000 epinephrine was gently applied
to widen the nasal cavity. The Xexible laryngoscope was
inserted to the oropharynx, and the probes were placed in
contact with the tip of the epiglottis and the arytenoid
region mucosa (at a non-tumour site in cases of hypopha-
ryngeal cancer). SuYcient contact was made so that there
was a slight bending of the probe (Fig. 2). The Xexible
laryngoscope and probes were manipulated, whenever pos-
sible, by the same person. Patients were asked to ring a
buzzer or tap their hand when they felt the probe. For
objective evaluation, the laryngeal adductor reXex was
observed. Agreement between the subjective and objective
Table 1 Patients’ characteris-
tics
No. Age Sex Tumour site TMN Radiotherapy 
dose (Gy)
Chemotherapy Operation
1 73 M Hypopharynx T1N0M0 70 None
2 78 M Larynx T3N2cM0 66 None
3 65 M Hypopharynx T2N0M0 60 Concomitant
4 74 M Larynx T2N2bM0 70 Concomitant ND
5 63 M Larynx T1bN0M0 60 Concomitant
6 70 M Larynx T1aN0M0 70 None
7 58 M Hypopharynx T1N0M0 66 Concomitant
8 69 M Hypopharynx T4bN2cM0 60 Concomitant
9 59 F Larynx T1aN0M0 70 None
10 73 M Larynx T2N0M0 70 Concomitant
11 53 M Larynx T1N2bM0 66 Concomitant ND
12 59 M Larynx T2N0M0 60 Concomitant
ND neck dissection
Fig. 1 Flexible laryngoscopes and probes. The upper left photo shows
all of the Xexible laryngoscopes. The lower left photo compares the tips
of the laryngoscopes. The top is a conventional Xexible laryngoscope,
and the bottom is the novel, thinner, and Xexible laryngoscope. The
right photo is a magniWed view of the probe tips. The nylon Wlament
diameters are a 0.06, b 0.13, c 0.2, and d 0.3 mm
a
b
c
A conventional flexible laryngoscope
d
A novel flexible laryngoscope
a:0.06 b:0.13
c:0.2 d:0.3Eur Arch Otorhinolaryngol (2010) 267:811–816 813
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Wndings was considered “positive.” Testing started with the
thinnest probe, and the sensation level was based on the
probe giving two of three positive responses.
Testing was performed four times; before radiotherapy,
1, 3 months, and 1 year after completing radiotherapy.
Testing was stopped when the patient had severe pain or a
strong gag reXex.
The Wilcoxon-signed rank test with Bonferroni correction
was used to conWrm signiWcant diVerences between each
testing time. A correlation between the sensation levels of the
epiglottis and the arytenoid region was analysed using the
Spearman’s rank correlation. Comparison of sensation levels
between mild mucositis and severe mucositis was analysed
using the repeated measures analysis of variance test.
The grade of radiation mucositis was classiWed based on
the National Cancer Institute’s Common Terminology Cri-
teria for Adverse Events v.3 (Table 2).
Results
Laryngeal paralysis did not occur before or after treatment
in any patient, and arytenoid adduction during phonation
was preserved. In patients 8 and 9, sensation testing 1 year
after radiotherapy was cancelled because of lung metastasis
and personal reasons, respectively.
Figure 3 shows the results of laryngeal sensation testing
and the grade of radiation mucositis. Mucositis was mild in
seven patients (grade 1 in 1 patient, grade 2 in 6 patients)
and severe in Wve patients (grade 3 in 5 patients). All
patients showed sensory deterioration of the epiglottis and/
or the arytenoids until 3 months after radiotherapy. One
year after radiotherapy, 60% of patients showed the same
sensation levels in the epiglottis as before radiotherapy, or
better sensation levels than at 1 or 3 months after radiother-
apy. With respect to arytenoids sensation, 90% of patients
showed the same sensation levels as before radiotherapy or
better sensation levels than at 3 months after radiotherapy.
With respect to sensation of the epiglottis, the Wilcoxon-
signed rank test with Bonferroni correction showed a sig-
niWcant deterioration (P < 0.017) in sensation 1 and
3 months after radiotherapy compared with before radio-
therapy. However, there was no signiWcant diVerence in
sensation 1 year after radiotherapy when compared with
before radiotherapy (P = 0.04). With respect to arytenoids
sensation, the Wilcoxon-signed rank test with Bonferroni
correction showed a signiWcant deterioration (P < 0.017) in
sensation 1 and 3 month after radiotherapy when compared
with before radiotherapy, but at 1 year, the diVerence was
not signiWcant when compared with before radiotherapy
(P = 0.12). There was a signiWcant correlation (P < 0.0001)
between the sensation levels of the epiglottis and the aryte-
noid region on the Spearman rank correlation.
Figure 3 also compares the sensation levels between
mild mucositis and severe mucositis; there were no signiW-
cant diVerences on the repeated measures analysis of vari-
ance test for both the epiglottis (P = 0.09) and the arytenoid
region (P = 0.58).
Discussion
Radiotherapy of the laryngopharynx sometimes leads to
functional disabilities including swallowing dysfunction
[2–5]. The reasons for these disabilities are mucosal and
muscular inXammation,  Wbrosis, reduced saliva secretion
and deterioration of laryngeal sensation [4]. Laryngeal
Fig. 2 Laryngoscopic Wndings 
during measurement. The nylon 
Wlament extending out from the 
sheath tip is in contact with the 
epiglottis and the arytenoid 
region
Table 2 Radiation mucositis classiWcation based on the National Can-
cer Institute’s Common Terminology Criteria for Adverse Events v.3
Grade 1 Erythema of the mucosa
Grade 2 Patchy ulcerations or pseudomembranes
Grade 3 ConXuent ulcerations or pseudomembranes; 
bleeding with minor trauma
Grade 4 Tissue necrosis; signiWcant spontaneous bleeding; 
life-threatening consequences
Grade 5 Death814 Eur Arch Otorhinolaryngol (2010) 267:811–816
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sensation is an important factor in swallowing [11], and we
decided to evaluate laryngeal sensation. Procedures for test-
ing laryngeal sensation by laryngoscope include Wberoptic
endoscopic evaluation of swallowing with sensory testing
(FEESST) with an air-puV stimulator, as described by Aviv
et al. [10], direct mucosal contact with a Xexible laryngo-
scope, and the use of probes, as discussed in the present
report. FEESST is a minimally invasive procedure to quan-
tify sensation by air pulses stimulating the laryngeal
mucosa at a constant pressure and time [13–16], but the
need for a special air-puV stimulator has limited its use.
Direct contact with a Xexible laryngoscope is simple, but it
is not very quantitative, with large inter-operator variabil-
ity. Our method using probes, originally described by Yag-
uchi et al. [12], permits semiquantitative evaluation, is
minimally invasive, and is convenient for use in clinical
settings; it allowed us to evaluate changes in laryngeal sen-
sation before and after radiotherapy.
First, the test method used in the present study and its
development are described. The novel narrow Xexible
laryngoscope with probe port was considered more appro-
priate for sensation testing because it was less irritating and
unlikely to touch other sites during testing. In selecting an
appropriate diameter of nylon Wlament to use with this
method, Yaguchi et al. [12] considered Semmes–Weinstein
monoWlaments, which are used to measure tactile sensation
by pressing nylon Wbres against the skin. However, the
thinnest commercially available nylon Wlament (diameter,
0.13 mm), in a kit from Arkray Inc. (Kyoto, Japan), is ade-
quately perceived by the tongue. Therefore, Yaguchi et al.
[12] decided to develop a thinner nylon Wlament with half
the diameter (0.06 mm), and selected four sizes of nylon
Wlaments for testing: 0.06, 0.13, 0.2, and 0.3 mm. We con-
sidered these sizes optimal for sensation testing, and the
same size nylon Wlaments were used in the present study.
Our selection of measurement sites (the epiglottic tip and
the arytenoid) was also based on the previous research [12].
These areas are innervated mainly by the superior laryngeal
nerve, have a dense distribution of sensory Wbres, and are
relatively accessible to testing.
In determining the sensation level, Aviv et al. [16] and
Yaguchi et al. [12] used subjective and objective Wndings,
and a “positive” sensory response was based on the agree-
ment between Wndings. Both authors reported a high corre-
lation between Wndings. Therefore, in the present study, as
in previous research, a “positive” response was based on
the agreement between subjective and objective Wndings.
When evaluating laryngeal sensation using a Xexible
laryngoscope, Yaguchi et al. [12] limited the number of
contacts to avoid patient discomfort, and estimated the sen-
sation level based on two of three positive responses.
Accordingly, in the present study, sensation level was
based on two of three positive responses. Although increas-
ing the number of contacts may improve repeatability and
precision, we were concerned that increasing the number of
contacts might be painful and uncomfortable for patients
and may increase the study dropout rate.
Next, the measurement results are described. In this
study, in both the epiglottis and the arytenoid, laryngeal sen-
sation deteriorated signiWcantly 1 and 3 month after radio-
therapy compared with before radiotherapy. Parise et al. [14]
evaluated laryngeal sensation in patients with dysphagia by
FEESST, and they reported a direct association between
radiotherapy of the head and neck and severe laryngeal sen-
sation deWcits. The present study also clearly demonstrates
the deterioration of laryngeal sensation with radiotherapy.
On the other hand, 1 year after radiotherapy, there was no
signiWcant diVerence compared with before radiotherapy for
both the epiglottis and the arytenoid. As mentioned in our
results, most patients showed the same sensation levels as
before radiotherapy, or better sensation levels than 3 months
Fig. 3 The sensation levels of the epiglottis and arytenoid; before, 1,
3 months, and 1 year after radiotherapy in each patient. Closed symbols
(Wlled circle, Wlled triangle, Wlled square, Wlled diamond, Wlled invert-
ed triangle) are the severe mucositis group; other symbols are the mild
mucositis group
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after radiotherapy. Laryngeal sensation tended to recover
1 year after radiotherapy. However, we suggest the testing
should be repeated 2 or 3 years after radiotherapy. Accord-
ing to Dietz et al. [2], 16% of patients who underwent
chemoradiatiotherapy for larynx/hypopharynx carcinoma
still showed dysphagia 3 years after chemoradiotherapy.
In the present study, a signiWcant correlation was
observed between the sensation levels of the epiglottis and
the arytenoid region. The probes could be inserted into the
forceps port of a conventional Xexible laryngoscope. There-
fore, in cases where tests are conducted using a conven-
tional laryngoscope with a rather long diameter with a
forceps port, or where measurement in the arytenoid region
is diYcult due to severe pain, it may be possible to deter-
mine deterioration of sensation in the arytenoid region to
some degree by measuring the sensation in the epiglottis.
The reasons for deterioration of laryngeal sensation after
radiotherapy need to be considered. Bodin et al. [17]
reported that a dose of 64 Gy in the head and neck Weld can
damage sensory nerves. Another study reported peripheral
neuropathy in 75% of patients receiving radiotherapy doses
of 63 Gy [18]. Neuropathologic features in peripheral neu-
ropathy include necrosis and hyalinization of the media of
small arteries, Wbrous replacement of nerve Wbres, demye-
lination, and Wbrosis of the nerve sheath [19]. In the present
study, 3 of 12 patients received 60 Gy, and the other 9
patients had doses of 66–70 Gy; thus, peripheral neuropa-
thy was highly likely.
The loss of sensory receptors was also considered
because, in a study on taste dysfunction in patients receiv-
ing radiotherapy to the oropharynx, pathologic analyses
showed diminished taste buds [20]. In the same manner,
radiotherapy of the laryngopharynx probably causes loss of
sensory receptors.
In the present study, there was no signiWcant diVerence in
sensory deterioration and sensory recovery between the
severe radiation mucositis group and the mild radiation
mucositis group. However, based on the underlying mecha-
nism, a correlation between grade of radiation mucositis and
deterioration of laryngeal sensation is possible. This issue
must be further investigated by accumulating more cases.
Finally, there have been reports of peripheral paresthesia
caused by anticancer agents [21–23]. In the present study,
we did not Wnd a signiWcant diVerence in deterioration and
recovery of sensation with the combination of chemother-
apy and radiotherapy, but this issue must also be further
investigated by accumulating more cases.
Conclusion
A novel procedure using a Xexible laryngoscope and probes
allowed convenient evaluation of changes in laryngeal
sensation in patients before and after radiotherapy. In both
the epiglottis and the arytenoid, laryngeal sensation deterio-
rated signiWcantly after radiotherapy. One year after radio-
therapy, laryngeal sensation recovered in most cases.
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